Literature DB >> 32451589

The formin INF2 in disease: progress from 10 years of research.

Leticia Labat-de-Hoz1, Miguel A Alonso2.   

Abstract

Formins are a conserved family of proteins that primarily act to form linear polymers of actin. Despite their importance to the normal functioning of the cytoskeleton, for a long time, the only two formin genes known to be a genetic cause of human disorders were DIAPH1 and DIAPH3, whose mutation causes two distinct forms of hereditary deafness. In the last 10 years, however, the formin INF2 has emerged as an important target of mutations responsible for the appearance of focal segmental glomerulosclerosis, which are histological lesions associated with glomerulus degeneration that often leads to end-stage renal disease. In some rare cases, focal segmental glomerulosclerosis concurs with Charcot-Marie-Tooth disease, which is a degenerative neurological disorder affecting peripheral nerves. All known INF2 gene mutations causing disease map to the exons encoding the amino-terminal domain. In this review, we summarize the structure, biochemical features and functions of INF2, conduct a systematic and comprehensive analysis of the pathogenic INF2 mutations, including a detailed study exon-by-exon of patient cases and mutations, address the impact of the pathogenic mutations on the structure, regulation and known functions of INF2, draw a series of conclusions that could be useful for INF2-related disease diagnosis, and suggest lines of research for future work on the molecular mechanisms by which INF2 causes disease.

Entities:  

Keywords:  Actin; Charcot–Marie–Tooth disease; Chronic kidney disease; Focal segmental glomerulosclerosis; Genetic disorder; Peripheral neuropathy

Mesh:

Substances:

Year:  2020        PMID: 32451589     DOI: 10.1007/s00018-020-03550-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  9 in total

1.  Molecular Study of Childhood Steroid-Resistant Nephrotic Syndrome: A Hospital-Based Study.

Authors:  Akanksha Singh; Ankur Singh; Om Prakash Mishra; Rajniti Prasad; Gopeshwar Narayan; Vineeta V Batra; Mansoureh Tabatabaeifar; Franz Schaefer
Journal:  J Pediatr Genet       Date:  2021-02-09

2.  Myosin II proteins are required for organization of calcium-induced actin networks upstream of mitochondrial division.

Authors:  Frieda Kage; Miguel Vicente-Manzanares; Brennan C McEwan; Arminja N Kettenbach; Henry N Higgs
Journal:  Mol Biol Cell       Date:  2022-04-15       Impact factor: 3.612

Review 3.  Role of formin INF2 in human diseases.

Authors:  Yiting Zhao; Hui Zhang; Haibiao Wang; Meng Ye; Xiaofeng Jin
Journal:  Mol Biol Rep       Date:  2021-10-26       Impact factor: 2.316

Review 4.  Genetic Neuropathy Due to Impairments in Mitochondrial Dynamics.

Authors:  Govinda Sharma; Gerald Pfeffer; Timothy E Shutt
Journal:  Biology (Basel)       Date:  2021-03-26

Review 5.  INF2 p.Arg214Cys mutation in a Chinese family with rapidly progressive renal failure and follow-up of renal transplantation: case report and literature review.

Authors:  Wenbo Zhao; Xinxin Ma; Xiaohao Zhang; Dan Luo; Jun Zhang; Ming Li; Zengchun Ye; Hui Peng
Journal:  BMC Nephrol       Date:  2021-02-04       Impact factor: 2.388

Review 6.  Using Drosophila Nephrocytes to Understand the Formation and Maintenance of the Podocyte Slit Diaphragm.

Authors:  Joyce van de Leemput; Pei Wen; Zhe Han
Journal:  Front Cell Dev Biol       Date:  2022-02-21

Review 7.  Formins in Human Disease.

Authors:  Leticia Labat-de-Hoz; Miguel A Alonso
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

8.  A Case of Focal Segmental Glomerulosclerosis.

Authors:  Jonathan J Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-09       Impact factor: 10.614

Review 9.  Lysine acetylation of cytoskeletal proteins: Emergence of an actin code.

Authors:  Mu A; Casey J Latario; Laura E Pickrell; Henry N Higgs
Journal:  J Cell Biol       Date:  2020-12-07       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.